NCT04756531 - STUDY OF PF-07321332 IN HEALTHY PARTICIPANTS | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 11, 2021

Primary Completion Date

September 1, 2021

Study Completion Date

September 1, 2021

Conditions

Healthy Participants

Interventions

DRUG

PF-07321332 Dose 1

PF-07321332 Dose 1 or Placebo

DRUG

PF-07321332 Dose 2

PF-07321332 Dose 2 or Placebo

DRUG

PF-07321332 Dose 3

PF-07321332 Dose 3 or Placebo

DRUG

PF-07321332 Dose 4

PF-07321332 Dose 4 or Placebo

DRUG

PF-07321332 Dose 5

PF-07321332 Dose 5 or Placebo

DRUG

PF-07321332 Dose 4 or Placebo (Fed)

PF-07321332 Dose 5 or Placebo with high fat meal

Trial Locations (2)

New Haven Clinical Research Unit, New Haven

Pfizer Clinical Research Unit - Brussels, Brussels